Chapel Hill, NC (December 8, 2021) – Devana Solutions is happy to announce a new client-partnership with Aventiv Research, a leading independent, multi-therapeutic clinical research center with seven locations across the greater Columbus, Ohio and Phoenix, Arizona regions. As an alliance partner of hyperCORE International, a super network of highly experienced and awarded clinical research companies, Aventiv’s mission is to enrich the lives of their team members and patients by putting medical research to work.
Founded in 2007 by Dr. Samir Arora, Aventiv Research has conducted over 475 clinical trials with more than 55 pharmaceutical sponsors and has assisted in the FDA approval of 23 medications available for use today. In addition to their research work and with over 30 years combined experience, Aventiv offers consulting services covering business development, site auditing and operations management, providing proper guidance on SOP implementation, quality assurance, staffing and infrastructure to ensure efficient and streamlined processes.
As a proven leader in the clinical trials industry, Aventiv has chosen to partner with Devana Solutions, the industry’s leading cloud-based technology provider, to help save time through workflow automation, from initial study lead through completion. “In addition to time saved, we now have robust, real-time clinical trial performance metrics to help improve trial execution and better align with our sponsors’ needs,” offered Dr. Samir Arora, President and Medical Director of Aventiv Research. “Devana’s data offerings support our goal to increase clinical trial efficiency.” Devana technology will reduce clinical trial cycle time, costs and ultimately, speed therapies to the market faster.
“I am pleased to have known Samir Arora for several years with Dr. Arora being a longtime leader in the clinical trials industry,” said Devana Solutions CEO, Barry Lake. “It’s humbling that so many of the industry leaders trust our Devana platform for metrics capture and analytics and connecting central teams to decentralized sites, and we’re very honored Dr. Arora and Aventiv Research have also placed their trust in Devana Solutions and our innovative platform.”
With an already excellent reputation for clean and quality data, it comes as no surprise that the Aventiv Research team has chosen to partner with Devana Solutions. “Our access to even more data sets will allow us to help advance our goal of expanding our expertise across vaccine, internal medicine, dermatology, and many other therapeutic areas,” added Rachel Flora, Business Development Manager for Aventiv. “As we gear up for 2022, the partnership with Devana has created a landscape for success for Aventiv. We will continue to work as a collaborative group by sharing insight and achievements to further set our network apart from our competitors.” The Devana team is excited to support this well-respected research organization to advance the clinical trials industry forward.
ABOUT AVENTIV RESEARCH:
Aventiv Research exists to make novel medicines accessible to its patients and deliver industry-best pharmaceutical data to its sponsors. Its mission is to enrich the lives of both its team members and patients by putting medical research to work. Currently operating in two states with seven independent research sites, Aventiv specializes in phase I-IV pharmaceutical, device, and diagnostic clinical trials in various therapeutic areas. Built on the core values of dedication, integrity, resourcefulness, and professionalism, the company embraces a visionary, entrepreneurial spirit that compels its ambassadors to blaze new trails with proprietary systems and processes.
ABOUT DEVANA SOLUTIONS LLC:
Devana Solutions®, LLC is a cloud SaaS provider driven by a core belief that data transparency through technology is critical to the selection of the top-performing research sites to align with pharmaceutical Sponsors and CROs to reduce drug development costs and cure disease.
Devana Solutions® flagship platform, IGNITE, allows integrated site networks and research organizations to standardize workflows, particularly in study startup, across site functions while allowing for the capture and display of performance metrics for dashboarding and analytics beyond site CTMS. PROPEL extends performance data transparency across Academic Research Institutions or an expanded network of owned and affiliated investigative sites. IQ allows for the sharing of performance data and documents in real-time between investigative sites and Sponsor or CRO stakeholders. To learn more visit www.devanasolutions.com.